Detay

French biotechnology company, specialised in custom-manufacture of products and management of R & D projects, is looking for services and outsourcing agreements

BOFR20150804002

This French biotechnology company designs specific solutions in bacteriology, microbiology and molecular biology. It is specialised in custom-manufacture of products and management of R & D projects. It is looking for services and outsourcing agreements with new partners who need capabilities and competencies in the fields mentioned above.

The company works with its clients in a highly collaborative manner combining scientific expertise with a culture of quality and integrity thus delivering results and a service they can trust. Its service is truly bespoke and individually tailored. The company values are built upon excellence and collaboration: it builds long-lasting relationships, in essence becoming an integral part of its clients' team. To ensure the highest level of quality for its customers, the company is certified ISO 9001:2008 for bacteriology and molecular biology services: analysis, production, R&D so that the company offers rigorous and reliable performance monitored at all stages by qualified staff, flexibility and responsiveness to changes during the research contracts, one to one direct contact during projects while respecting absolute confidentiality. The company is accredited by the French Ministry of Research and Higher Education under the Research Tax Credit. After winning the 2013 national competition for assistance in the creation of innovative technology companies in the "emerging" category, the company was in 2014 the winner of the same competition in the "creation-development" category. The company has acquired more than 10 internationally recognized references and developed several businesses or technical collaborations with well-known partners in the field of bio and microtechnologies. It has particularly developed business partnerships in Germany and Switzerland.

Created by two young PhD in bacteriology, the French company has focused its mission on assisting public and private research laboratories in carrying their projects. It is now seeking to extend its biotechnology services abroad thanks to services and outsourcing agreements. Relying on its research abilities, the French company works with its customers according 3 interconnected models: (1) External production service model (services agreement) From an existing procedure or a procedure developed specifically for the customer, the French company performs routine calibrated tests according to the customers’ needs. (2) Functional outsourcing model: Customers outsources “parts” of their own R&D program and the French company designs and performs specific one shot experiments according to the customers’ needs. (3) Fully managed model (outsourcing): Customers externalize the entire R&D program and the French company takes on a greater level of responsibilities for the overall R&D program. The dynamic company develops various individualized and customized services in the field of microbiology and molecular biology by using research capabilities of the founders and specific tools listed below: • Creation of knock-out bacteria: The company performs gene inactivation by using a homologous recombination technique leading to the total deletion of a targeted gene without leaving any additional DNA sequences (antibiotic resistance cassettes). The company can construct for its clients the deletion mutants (knockout) they need in different gram negative bacteria such as Pseudomonas aeruginosa, Pseudomonas fluorescens, Klebsiella pneumoniae, Acinetobacter baumannii or other bacteria on request. • Measurement of the activity of anti-bacterial molecules: The company can perform in vitro determination of the sensitivity of bacterial strains to various drugs, such as antibiotics, antiseptics, dyes, etc., through a panel of methods (antibiogram, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) determination, fractional inhibitory concentration (FIC) index measurement, bactericidal curve, phage plaque assay, etc…). The French company has its own collections of characterized clinical strains (Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus aureus). • Detection, identification and quantification of microorganisms (bacteria, molds, yeasts): The company can identify and quantify the microorganisms (bacteria, molds, yeasts) or specific targets (genes, enzymes, etc…) potentially present in a sample (blood, skin, soil, sludge, water, etc…), on a surface or in the air by using culture, 16S RNA sequencing or mass spectrometry. • Next generation sequencing: The company can provide, by using high-throughput sequencing technologies, genomic and metagenomics services such as whole bacterial genome sequencing, RNA sequencing or metagenomics and metatranscriptomics experiments (e.g. microbiota analysis). • Analytical and production services: The company has developed an analytical platform able to performed various services in bacteriology (clonality assessment through genotypic analysis, measurement of bacterial growth under different conditions, co-culture competition experiments, study of virulence factors production) and in molecular biology, DNA amplification by using: Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Real Time qPCR (RT-qPCR), Rolling Circle Amplification PCR (RCA PCR), Southern blotting, gene sequencing, mycoplasma detection, DNase and RNase detection etc. The company provides also customized production services by extracting DNA, RNA, plasmids, or cloning genes in vectors. The French company can offer all these specificities, advanced techniques under services and outsourcing agreements in a total confidentiality, reliability and in a long term collaborat

21.9.2016

8.9.2015

22.9.2015

Keyword

06002002Nuclear
06002005Genetic Engineering
06002007In vitro Testing, Trials
06002008Microbiology
06002009Molecular design

05001001Diagnostic services
05001002In-vitro diagnostics
05001005Molecular diagnosis
05006Anatomy, Pathology, Immunology, Physiology

M.72.1.1Research and experimental development on biotechnology

İş Birliği

Private (in-house) research

The French biotechnology company is looking for services and outsourcing services with industrial companies, research centers and laboratories institutions to offer them its large panel of competencies. The type of partners sought could be: laboratories, hospitals, research centers, medical devices suppliers, medicine manufacturers, pharmaceutical companies, industrial companies involved in the field of cosmetics, medical diagnosis, medical devices, pharmaceuticals, aeronautics, health, environment... Reliable and in a long term collaborations are particularly required. Specifications, contracts of confidentially will be required. Services and outsourcing agreements: All type of microbiology, molecular biology services or outsourcing agreements, mentioned in the description, are sought with future partners. The main countries currently prospected by the company are: Denmark, Spain, United-Kingdom, Germany, Slovakia, Italy, Switzerland, Algeria, but all other countries are welcome.

SME 11-50,R&D Institution,SME <10,>500 MNE,251-500,SME 51-250,>500

Already on the market

Alan

Bio Chem Tech

Müşteri

Industry SME <= 10

English French

France

<1M

Evet

Services agreement Outsourcing agreement